Rossini, M., et al. “Why Golimumab in the Treatment of Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis?”. Reumatismo, vol. 66, no. 4, Mar. 2015, pp. 285-03, doi:10.4081/reumatismo.2014.799.